Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Karolinska Institutet Stockholm County Council Aerocrine AB Phadia AB Meda AB Swedish Research Council Swedish Council on Working Life and Social Research MSD Sweden |
---|---|
Information provided by: | Karolinska Institutet |
ClinicalTrials.gov Identifier: | NCT00421018 |
The purpose of this study is to determine whether use of exhaled NO (nitric oxide) to regulate the anti-inflammatory treatment leads to increased asthma-related quality of life in patients with allergic asthma
Condition | Intervention |
---|---|
Allergic Asthma |
Device: Use of exhaled NO as a guide to regulate asthma treatment |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Optimization of the Anti-Inflammatory Treatment of Asthma Patients Through Exhaled NO Measurements for Increased Asthma-Related Quality of Life in Primary Health Care (NOAK) |
Ages Eligible for Study: | 18 Years to 64 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Jörgen Syk, M.D. | +46 8 590 990 60 | Jorgen.Syk@ptj.se |
Sweden | |
Karolinska Institutet | Recruiting |
Stockholm, Sweden, SE-171 76 | |
Principal Investigator: Kjell Alving, PhD |
Principal Investigator: | Kjell Alving, Ph.D | Karolinska Institutet |
Study ID Numbers: | 20050166 |
Study First Received: | January 10, 2007 |
Last Updated: | January 10, 2007 |
ClinicalTrials.gov Identifier: | NCT00421018 |
Health Authority: | Sweden: The Ministry of Education and Cultural Affairs |
Asthma Allergy Cytokines Glucocorticoids Inflammation |
Nitric Oxide (NO) Quality of Life Self-Rated Health Stress |
Nitric Oxide Lung Diseases, Obstructive Hypersensitivity Respiratory Tract Diseases Lung Diseases Hypersensitivity, Immediate |
Quality of Life Stress Asthma Respiratory Hypersensitivity Inflammation |
Immune System Diseases Bronchial Diseases |